$Standard BioTools(LAB.US)$Revenue was $46 million, up 81% year-over-year, with impact of SomaScan assay services, kits and related revenue in 2024; and -- Ended the quarter with cash, cash equivalents, restricted cash and short-term investments of $464 million, after accounting for $71 million cash payments for merger-related expenses, settlement of year-end operating accruals, debt retirement and completed stock buybacks.
$Standard BioTools(LAB.US)$Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging 2 MINUTES AGO, 8:00 AM EDT VIA GLOBENEWSWIRE
$Standard BioTools(LAB.US)$Standard BioTools Announces Multi-Year Strategic Engagement With Bristol Myers Squibb For Use Of The SomaScan Platform For Translational Medicine Research Through 2026 Benzinga· 1 min ago
$Standard BioTools(LAB.US)$Press Release: Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools
Standard BioTools股票討論區
assay services, kits and related revenue in 2024; and
-- Ended the quarter with cash, cash equivalents, restricted cash and
short-term investments of $464 million, after accounting for $71 million
cash payments for merger-related expenses, settlement of year-end
operating accruals, debt retirement and completed stock buybacks.
2 MINUTES AGO, 8:00 AM EDT
VIA GLOBENEWSWIRE
Benzinga· 1 min ago
• $National CineMedia(NCMI.US)$ +17.9% (AMC discloses 6.8% stake in NCMI)
• $MagnaChip Semiconductor(MX.US)$ +14.8% (report that private equity firms including Carlyle Group (CG) will bid for the company)
• $DLocal(DLO.US)$ +13.7% (In reaction to earnings)
• $SiriusPoint(SPNT.US)$ +8.2% (Chairman and CEO resigns to pursue other opportunities)
• $Beyond Air(XAIR.US)$ +6.4% (presents positive study update from the at-home LungF...
暫無評論